Editorial Staff

Study Finds MassHealth’s Enhanced Eligibility Verification Saves $250 Million a Year

/in , , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Reforms fixed MassHealth’s $1.2 billion eligibility crisis, freed up money to be redirected to needy recipients

BOSTON – Enhanced eligibility verification allowed MassHealth, the Commonwealth’s Medicaid program, to save significant resources that could be redirected to the care of truly needy Medicaid recipients, according to a new study published by Pioneer Institute.

Download "MassHealth Protecting Medicaid Resources for the Most Vulnerable"

“MassHealth’s success at digging out of an eligibility crisis that cost Massachusetts at least $658 million, according to the Commonwealth’s Health Policy Commission, holds important Medicaid eligibility lessons for other states,” said Dr. William J. Oliver, author of “MassHealth Protecting Medicaid Resources for the Most Vulnerable: How Massachusetts Saved Hundreds of Millions through Enhanced Eligibility Verification.”

After the failure of initial efforts to comply with Affordable Care Act rules that required the Commonwealth to change its eligibility systems, then-Gov. Deval Patrick obtained permission to suspend mandatory annual eligibility redeterminations and extend temporary Medicaid coverage to anybody who signed up, regardless of income.

In 2014, Medicaid operated for five months without any eligibility determinations, during which time 321,000 new beneficiaries were added, expanding MassHealth enrollment to more than two million or roughly 30 percent of the state’s population. Gov. Charlie Baker ended temporary coverage and MassHealth phased in enhanced eligibility measures to stabilize the program.

MassHealth began by conducting 1.2 million manual eligibility redeterminations over five months.

Beginning in October 2016, MassHealth tested a series of new eligibility matches to improve accuracy. At the end of 2016 and into 2017, MassHealth tested and then implemented additional external data matches such as new hire and earnings data and death registry information to further refine eligibility determinations.

In total more than $1.2 billion was saved. Most of the savings came from ending temporary coverage for those who did not qualify for MassHealth, but $250 million resulted from enhanced eligibility checks through automated matches.

One key to MassHealth’s eligibility redetermination success was testing new automated matches in batch mode before rolling them out systemwide.

“Additional automated data check opportunities hold the promise of further improving the eligibility redetermination process,” said Josh Archambault, a senior fellow at Pioneer.  “They include enhanced checks to verify residency, sharing eligibility information with public assistance programs, and using asset verification checks for more populations to signal changes in income that could impact Medicaid eligibility.”

About the Authors

Dr. William J. Oliver has transformed benefits eligibility sys­tems and processes in Texas, Florida, Indiana, Pennsylvania, Mississippi and Arkansas. He has outsourced, insourced, and retooled eligibility systems for both Medicaid and human ser­vices benefits. Dr. Oliver has built, selected, and implemented leading-edge systems in hospitals, pharmacy, retail, and oth­er industries, and has driven major benefits eligibility reform including the Mississippi Hope Bill. He is a CPA and holds a Masters in Management from MIT and a doctorate in Man­agement from Case Western. Dr. Oliver is a Principal at The Stephen Group and is published widely on healthcare business model innovation and assessing program outcomes.

Josh Archambault is a Senior Fellow at Pioneer Institute. Pri­or to joining Pioneer, Josh was selected as a Health Policy Fel­low at the Heritage Foundation in Washington, D.C. In the past, Josh served as a Legislative Director in the Massachu­setts State Senate and as Senior Legislative Aide in the Gov­ernor’s Office of Legislative Affairs. His work has appeared or been cited in outlets such as USA Today, Wall Street Journal, The New York Times, Fox News, NPR, Boston Herald and The Boston Globe. He is the editor and coauthor of The Great Exper­iment: The States, The Feds, and Your Healthcare. Josh holds a Master’s in Public Policy from Harvard University’s Kenne­dy School and a BA in Political Studies and Economics from Gordon College.

About Pioneer

Pioneer Institute is an independent, non-partisan, privately funded research organization that seeks to improve the quality of life in Massachusetts through civic discourse and intellectually rigorous, data-driven public policy solutions based on free market principles, individual liberty and responsibility, and the ideal of effective, limited and accountable government.

Get Updates On Our Healthcare Research and Events!

Related Posts:

Pioneer Institute: 340B Hospitals Does Not Necessarily Translate to Charity Care

Review of Becker’s List of Health Systems with Strong Finances…

New Online Tool Tracks MA Hospital Revenue from Commercial Sources

A new online tool from Pioneer Institute shows a gradual increase in non-commercial (public payer) revenue at Massachusetts hospitals and also reveals a strong relationship between the hospitals with the highest commercial revenue and those with the highest relative prices.

Telehealth Progress Slowed in 2023

A new report by Cicero Institute, Pioneer Institute, and Reason Foundation reveals worrying stagnation in state-level telehealth expansion efforts in 2023, with only a few exceptions. Progress made during the pandemic is being lost even as provider shortages worsen, raising concerns about patients’ access to care.

Opinion: Drug patents aren’t a ‘necessary evil.’ They save lives.

Drug patents are one of the most important public policy innovations in all of human history, and a boon to patients awaiting cures. Inventions only come when inventors are rewarded, not punished. Patents are not a “necessary evil.”

Study: High List Prices and Deep Discounts for Prescription Drugs Hurt Poor and Sick Patients

A new Pioneer Institute study illustrates how the current system of drug pricing and discounts leads to patients with challenging diseases being charged huge out-of-pocket sums to keep other premiums low, effectively imposing financial penalties on the sick to protect the healthy and wealthy.

Study: Massachusetts Should Join 45 States and Allow Prescribers to Dispense Medications

A Pioneer Institute study shows that middlemen—commercial pharmacies and pharmacy benefit managers—add substantial costs over wholesale prices. Allowing prescribers to dispense routine drugs would save consumers money without compromising safety.

As COVID-19 Emergencies Ease, Some Progress on Telehealth Rules

A new report from Reason Foundation, Cicero Institute and Pioneer Institute rates every state’s telehealth policy for patient access and ease of providing virtual care. The report highlights telehealth policy best practices for states.

First-of-Its-Kind Interactive Mapping Tool Reveals Extent of For-Profit Entities Benefitting from the 340B Drug Pricing Program

Today, Pioneer Institute released a first-of-its-kind, 50-state mapping tool and database highlighting the troubling way in which hospitals and covered entities leverage unlimited pharmacy contracts under the 340B Drug Pricing Program.

Survey Finds Spotty Compliance Among Hospitals with Federal Price Transparency Law

A 2019 federal law requires hospitals to make prices for 300 shoppable services available online in a “consumer-friendly format,” but a Pioneer Institute survey of 19 hospitals finds that information on discounted cash prices—the price most likely to be charged to consumers paying out of pocket—was unavailable at seven of those hospitals.

Massachusetts Hospitals Pull Back on Charity Care as Revenue from Federal 340B Drug Discount Program Explodes

Over the past decade, the revenue for hospitals generated by the federal 340B drug discount program, initially intended to serve low-income, uninsured populations, has exploded even while a number of important Massachusetts hospitals have reduced the level of charity care they provide, according to a new study published by Pioneer Institute. The Pioneer Institute study, “340B Drug Discounts: An Increasingly Dysfunctional Program,” notes that nationwide, 340B drug sales rose from $9 billion in 2014 to $38 billion in 2020.

The Promise and Challenges of Rare Cancer Treatments

Dr. William Smith, Pioneer Institute's Visiting Fellow in Life Sciences, spoke about the challenges and opportunities for rare cancer treatments, in a video interview produced by Rare Cancers, a patient group based in Australia, for the November 26th CAN Forum. 

Study: Decline in Cardiovascular Health Screenings During COVID-19 Pandemic Poses New Public Health Threat

Pioneer Institute today released a new analysis focused on cardiovascular disease, An “Impending Tsunami” in Mortality from Traditional Diseases?, that examines how the COVID-19 pandemic has created another unrelated public health crisis. The Pioneer analysis examines how a single-minded public health focus on COVID-19, social distancing, and lockdowns drove reductions in screenings, diagnoses, and early treatment for complex conditions such as heart disease.

Pioneer Institute Statement on the Commonwealth’s Discontinuance of the COVID-19 Weekly Public Health Report

Useful information about COVID cases or deaths at individual homes has become less available at a time when cases are increasing again, even among vaccinated residents. Pioneer urges Massachusetts to immediately reinstate the so-called Weekly Report, which contains cases and deaths inside individual nursing homes.

Study: Massachusetts Should Retain Additional Healthcare System Flexibility Granted During Pandemic

Massachusetts’ emergency declaration for COVID-19 ends on June 15, and with it some enhanced flexibility that has been allowed in the healthcare system.  Some of the added flexibility highlighted barriers that make the system more expensive, harder to access and less patient-centered, and the Commonwealth should consider permanently removing these barriers, according to a new study published by Pioneer Institute.

Study Calls for Better Reporting on Impact of COVID-19 in Eldercare Facilities

Over time, the Massachusetts Executive Office of Health and Human Services and Department of Public Health (DPH) have improved reporting about cases and deaths from COVID-19 in state-regulated eldercare facilities, but flaws and omissions remain and should be corrected, according to a new study published by Pioneer Institute.